Pharmaceutical Worker Examining a Pill, close-up

Article

PDF: Update on Drugs & Devices: May – June 2023

Name: PDF: Update on Drugs & Devices: May – June 2023
Price: 1.99 USD
Availability: InStock

$1.99

PDF Download: Update on Targeted alkali thermolysis (TAT) technology (Brella™ 3-miniute SweatControl Patch™), Retifanlimab-dlwr for IV infusion (Zynyz™), Spesolimab IV for IV infusion (Spevigo®) and CRISPR-based therapy (NTLA-2002).

Read online:
Update on Drugs & Devices: May – June 2023

Category: Dermatology

PDF: Update on Drugs & Devices: May – June 2023

Related products

PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses

PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma

PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea

PDF: Update on Drugs & Devices: September – October 2019